On the Nature of Hypertrophic Scars and Keloids: A Review

Niessen, Frank B.; Spauwen, P.H.M.; Schalkwijk, Joost; Kon, Moshe

doi:10.1097/00006534-199910000-00031

Cited by 725 publications

(718 citation statements)

References 275 publications

Supporting

Mentioning

684

Contrasting

Unclassified

Order By: Relevance

“…They ranked 23 rd for patients in the 15-39 age groups, and 24 th in complaints of Afro-descendant patients. In this study, keloids were more frequent among women, Afro-descendants and the 30 year old age group, corroborating literature [25][26][27][28] .…”

Section: Resultssupporting

confidence: 91%

What factors affect the quality of life of patients with keloids?

Furtado¹,

Hochman²,

Ferrara³

et al. 2009

Rev. Assoc. Med. Bras.

View full text Add to dashboard Cite

Section: Resultssupporting

confidence: 91%

What factors affect the quality of life of patients with keloids?

Furtado¹,

Hochman²,

Ferrara³

et al. 2009

Rev. Assoc. Med. Bras.

View full text Add to dashboard Cite

“…11 Keloid scars are benign collagenous tumors that form in the reticular layer of the dermis during a prolonged wound healing process in persons with a genetic predisposition. 147,148 They spread beyond the margins of the original wound and are associated with increased collagen deposition and fibroproliferation. [149][150][151] Both are associated with significant morbidity.…”

Section: 117mentioning

confidence: 99%

Chemokines in Wound Healing and as Potential Therapeutic Targets for Reducing Cutaneous Scarring

Rees¹,

Greaves²,

Baguneid

et al. 2015

Advances in Wound Care

View full text Add to dashboard Cite

“…We avoid using a lip split incision in Blacks because of a high incidence of a hypertrophic scar and keloid. 13 Supraperiosteal dissection with/without excision of overlying mucosa is indicated if the tumour perforates cortices. 3 We agree with the suggestion by Bui et al 14 that delayed or secondary reconstruction should be the treatment of choice in medically unstable patients, or when there are no local options such as available recipient vessels.…”

Section: A Rational Approach For Treating Ameloblastomamentioning

confidence: 99%

A treatment algorithm for managing giant mandibular ameloblastoma: 5-year experiences in a Paris university hospital

Chaine¹,

Pitak‐Arnnop²,

Dhanuthai³

et al. 2009

European Journal of Surgical Oncology (EJSO)

View full text Add to dashboard Cite

This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. FINDINGS:Forty-four ameloblastoma patients were operated during this study period. Sixteen cases had GMA, of which 9 patients were included in this series (mean age: 35 years). The defects in the mandible ranged from 7 to 16 cm in length (mean: 12 cm). The average length of the harvested fibula was 11 cm, and the number of osteotomies ranged from 1 to 2. The mean ischemic time was 137 minutes (range: 90-180 minutes).Neck recipient vessels were used for flap perfusion in all cases. All but one flaps were viable without any complications, whilst partial skin-island necrosis occurred in 2 patients. Hospital stay was 2 weeks in most of the patients. No tumour recurrence was found during the follow-up period (range: 26-73 months). Dental implants were placed in 2 patients. CONCLUSIONS:Despite several limitations of this study, we suggest that a radical approach with the SM-IFFOFR is an effective treatment for GMA. Further well-designed, larger series with longer follow-up periods are still encouraged.

show abstract

On the Nature of Hypertrophic Scars and Keloids: A Review

Cited by 725 publications

References 275 publications

What factors affect the quality of life of patients with keloids?

What factors affect the quality of life of patients with keloids?

Chemokines in Wound Healing and as Potential Therapeutic Targets for Reducing Cutaneous Scarring

A treatment algorithm for managing giant mandibular ameloblastoma: 5-year experiences in a Paris university hospital

Contact Info

Product

Resources

About